Stay updated on FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial

Sign up to get notified when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. The Study Details page content and layout appear unchanged.
    Difference
    0.1%
    Check dated 2025-12-01T17:39:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1; there are no changes to study data, eligibility criteria, or page content beyond the version label. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:32:32.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removal of the site-wide government funding notice; the study details and page navigation remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:46:48.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The screenshots show the same study record with minor visual/UI differences and no changes to core trial information such as eligibility criteria, enrollment, or study status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:15:51.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page now includes a government-funding lapse notice and a new v3.2.0 update, replacing the old v3.1.0 tag.
    Difference
    5%
    Check dated 2025-10-05T10:28:35.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page replaces some drug-safety topic links with a new version label (v3.1.0 added) and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Substandard Drugs, and the earlier Revision v3.0.2).
    Difference
    0.7%
    Check dated 2025-09-28T03:19:49.000Z thumbnail image

Stay in the know with updates to FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FG-3019 in Hepatitis B Liver Fibrosis Clinical Trial page.